Martin Delaney Collaboratories for HIV Cure Research
This grant supports collaborative research to develop strategies for curing HIV, aiming to eliminate the virus without lifelong therapy and addressing the needs of children with HIV.
Funder: National Institutes of Health (NIH)
Due Dates: August 19, 2026 (Forecasted)
Funding Amounts: Estimated total program funding: $20,000,000; ~6 awards expected
Summary: Supports collaborative research to develop strategies for controlling or eradicating HIV without lifelong antiretroviral therapy, including research focused on children.
Key Information: This is a forecasted opportunity; dates and details may change.
Description
The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, is forecasting continued support for the Martin Delaney Collaboratories (MDCs) for HIV Cure Research. This program aims to advance the development of strategies to control HIV replication without the need for lifelong antiretroviral therapy, with the ultimate goal of eradicating HIV reservoirs from individuals. Special emphasis is placed on addressing the unique needs of children living with HIV.
The MDC program fosters strategic collaborations among academic institutions, government scientists, private sector partners, and community stakeholders. By leveraging shared resources and specialized technologies, the program supports a broad spectrum of basic, translational, and clinical HIV cure research.
